Drug intelligence / Profile preview

Opti-Free

Development stage
Unknown
Lead developer
Alcon
Administration
Ophthalmic
01

Overview

Opti-Free is a brand of multi-purpose disinfecting solutions for soft contact lenses manufactured by Alcon Laboratories. The product line includes Opti-Free PureMoist and Opti-Free Replenish. **Opti-Free PureMoist** is a multi-purpose solution containing a proprietary HydraGlyde Moisture Matrix technology. It is used to clean, disinfect, rinse, store, and recondition soft contact lenses, including silicone hydrogel lenses. Key ingredients include Sodium citrate, Sodium chloride, Boric acid, Sorbitol, Aminomethylpropanol, Disodium EDTA, and wetting agents like TETRONIC 1304 and HydraGlyde Moisture Matrix (EOBO-41-polyoxyethylene-polyoxybutylene). It contains preservatives POLYQUAD (polyquaternium-1) 0.001% and ALDOX (myristamidopropyl dimethylamine) 0.0006%. **Opti-Free Replenish** is another solution in the line featuring the TearGlyde reconditioning system instead of HydraGlyde, serving similar contact lens care purposes. Both products offer: * **Disinfection**: Utilizing POLYQUAD and ALDOX to kill 99.9% of germs. * **Moisture/Comfort**: PureMoist uses HydraGlyde for hydration; Replenish uses TearGlyde. * **Cleaning**: Removes protein and reduces lipid deposits. * **Compatibility**: Suitable for silicone hydrogel and soft (hydrophilic) lenses. * **Storage**: Allows lens storage for up to 30 days after disinfection. The recommended use involves a 5-step cleaning, rinsing, and storing process.

Brand names
Opti-FreeOpti-Free PureMoistOpti-Free Replenish
Other names
Opti-Free-Christine Sindt
02

Targets

AR (Adrenergic receptors)

Beyond the preview

Go deeper on Opti-Free.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Opti-Free.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call